Diasome Pharmaceuticals, Inc. — Form D

Diasome Pharmaceuticals, Inc. of CLEVELAND, OH, a company, filed a Form D exempt-offering notice with the SEC on 2018-10-26. The offering totals $18.6M, of which $12.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
W. Blair GehoDirectorCleveland, OH
Frank McCaneyDirectorPhiladelphia, PA
Thomas McDonaldDirectorMiami, FL
Marc PennDirectorCleveland, OH
Devang KantesariaDirectorMiami, FL
Peter Blair TollmanDirectorCleveland, OH
Robert GehoDirectorCleveland, OH
Robert GehoExecutive OfficerCleveland, OH
Robert GehoPromoterCleveland, OH
Frank Blair McCaneyDirectorCleveland, OH
W. Blair GehoDirectorCleveland, OH
W. Blair GehoExecutive OfficerCleveland, OH
Thomas Blair McDonaldDirectorCleveland, OH
Cosme Blair OrdonezDirectorCleveland, OH
Marc Blair PennDirectorCleveland, OH
Michele Blair OllierDirectorCleveland, OH
Helga Blair KautskyExecutive OfficerCleveland, OH
Guiseppe Blair ZoccoDirectorCleveland, OH
Richard Blair CarusoDirectorCleveland, OH
Len RosenbergDirectorConshohocken, PA
Len RosenbergExecutive OfficerConshohocken, PA
Richard CarusoDirectorVillanova, PA
Brenda GavinDirectorPhiladelphia, PA

Other filings by this issuer (7)

FiledFormOfferingSold
2024-08-15D$15.6M$3.1M
2023-06-30D$15.0M$9.0M
2022-09-08D$19.1M$16.7M
2020-12-23D$5.0M$1.5M
2020-04-01D$2.9M$2.9M
2017-01-17D$8.0M$4.3M
2009-04-13D/A$13.4M$12.9M

More